Cargando…
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor
Self-inactivating lentiviral vectors (LVVs) are used regularly for genetic modification of cells, including T cells and hematopoietic stem cells for cellular gene therapy. As vector demand grows, scalable and controllable methods are needed for production. LVVs are typically produced in HEK293T cell...
Autores principales: | Powers, Alicia D., Drury, Jason E., Hoehamer, Christopher F., Lockey, Timothy D., Meagher, Michael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490643/ https://www.ncbi.nlm.nih.gov/pubmed/32995355 http://dx.doi.org/10.1016/j.omtm.2020.08.010 |
Ejemplares similares
-
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018) -
Construction of stable packaging cell lines for clinical lentiviral vector production
por: Sanber, Khaled S., et al.
Publicado: (2015) -
Assessment of packed bed bioreactor systems in the production of viral vaccines
por: Rajendran, Ramya, et al.
Publicado: (2014) -
Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells
por: Osiecki, Michael J., et al.
Publicado: (2015) -
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
por: Hu, Peirong, et al.
Publicado: (2015)